Specifications tableSubject area*Biology*More specific subject area*Biochemistry, Computational Biology and Data mining, phylogenetic analysis, SR protein kinases*Type of dataTables, figuresHow data was acquired*SRPK1a nucleotide and protein sequences were retrieved from NCBI Nucleotide and Protein databases. RNA-seq data are publicly available in the Gene Expression Omnibus (GEO) repository. Mass spectrometry data are publicly available in the EMBL-EBI PRoteomics IDEntifications (PRIDE) database.*Data formatRaw and analyzedExperimental factors*Nucleotide and protein sequences were retrieved from online databases and used for detection of sequence conservation and phylogenetic analysis*Experimental features*Sequence similarity searches and multiple sequence alignments were performed using SRA BLASTN, BLASTP and COBALT. The PeptideMass tool was used to retrieve in silico specific SRPK1a peptide sequences and match them with mass spectrometry data available from the PRIDE database. Evolutionary analyses and drawing of the phylogenetic tree were conducted using MEGA6*Data source location*Analyses were performed at the Aristotelian University, Thessaloniki Greece and the National Centre for Scientific Research "Demokritos", Athens, Greece*Data accessibilityData are provided with this article**Value of the data**•The presented data support the expression of SRPK1a in a variety of mammalian organisms and therefore, they may boost future research probing into the contribution of SRPK1a to SRPK1 functions.•Protein sequencing alignments provide information on the highly variable N-terminal domain of SRPK1a. These data will feed into the development of specific tools and experimental approaches for the genetic and biochemical analysis of SRPK1a function.•Phylogenetic analysis provides information on the evolutionary history of the SRPK1 gene and may lead to further downstream studies.

1. Data {#sec1}
=======

[Table 1](#tbl1){ref-type="table"} is an alignment of the additional SRPK1a mRNA 23-535nt region (Nikolakaki et al., 2001) [@bib1], not found in SRPK1, against RNA-Seq reads of erythroid cell populations [@bib2]. [Fig. 1](#fig1){ref-type="fig"} is a conservation-based colored alignment of partial SRPK1a sequences that contain only the additional N-terminal part of the kinase, in mammals. [Table 2](#tbl2){ref-type="table"} is a list of peptides originated from *in silico* trypsin digestion of SRPK1a 22-534nt translated region that returned a match in PRIDE database [@bib3], [@bib4]. [Fig. 2](#fig2){ref-type="fig"} is a phylogenetic tree obtained by Maximum Likelihood method in MEGA6 [@bib5].Table 1Local alignment of the 23--535 nt segment of SRPK1a mRNA (AJ318054.1), which corresponds to the retained intron that sets the difference between SRPK1a and SRPK1, against RNA-Seq reads of erythroid cell populations (GSE53635), using SRA BLASTN [@bib6]. Raw RNA-Seq data are publicly available in the Gene Expression Omnibus (GEO) repository and can be accessed using experiment (GSE_ID) or sample (SRA_ID) Accession IDs.Table 1GeneAccession_IDmRNA_regionGSE_IDSRA_IDCell_typeNo of_RNA-Seq_reads (100%)SRPK1a[AJ318054.1](ncbi-n:AJ318054.1){#intref0015}23--535GSE53635SRX398536proerythroblast27SRPK1a[AJ318054.1](ncbi-n:AJ318054.1){#intref0020}23--535GSE53635SRX398537early_basophilic7SRPK1a[AJ318054.1](ncbi-n:AJ318054.1){#intref0025}23--535GSE53635SRX398538late_basophilic6Fig. 1Conservation-based colored sequence alignment, drawn using the GeneDoc program [@bib9]. Nomenclatures are according to organism names. The corresponding accession numbers in the NCBI protein database are shown in [Fig. 2](#fig2){ref-type="fig"}. Coloring scale: red, blue, and grey, for 100%, 80% and 60% sequence conservation, respectively. Arrows denote the starting and ending amino acid residues (glycine and alanine, respectively) of the additional sequence which is found only in SRPK1a and is omitted in SRPK1.Fig. 1Table 2*In silico* trypsin digestion of SRPK1a 22--534 translated region. Below are shown the resulting peptides that returned a match in PRIDE database (PRD000004, human plasma proteome; PXD001383, chromatin-associated and soluble human transcription factor complexes; PXD000593, human CDK family protein complexes), as well as the local alignment identity score of SRPK1a (CAC39299.1) with the PRIDE peptide matches using BLASTP [@bib7].Table 2GeneAccession number*In silico* digestion positionTryptic peptidePRIDE database tryptic peptide matchPRIDE database Accession IDBLASTP top resultBLASTP identity score (%)SRPK1a[AJ318054.1](ncbi-n:AJ318054.1){#intref0030}94--113RPPPARPLTRPETPPAHPARRPPPARPLTRPETPPAHPARALLCAPWAASPPAASPPQPPPRPRD000004SRPK1a (CAC39299.1)95SRPK1a[AJ318054.1](ncbi-n:AJ318054.1){#intref0035}138--156QAPQPGLAPLLGLHPHLGRRQAPQPGLAPLLGLHPHLGR[PXD001383](pride:PXD001383){#intref0040}SRPK1a (CAC39299.1)100SRPK1a[AJ318054.1](ncbi-n:AJ318054.1){#intref0045}157--171LLSSTFALHPSLSPALLSSTFALHPSLSPAV[PXD001383](pride:PXD001383){#intref0050}SRPK1a (CAC39299.1)100SRPK1a[AJ318054.1](ncbi-n:AJ318054.1){#intref0055}80--92ALGPLQGPALGGRRALGPLQGPALGGR; ALGPLQGPALGGR[PXD001383](pride:PXD001383){#intref0060}; [PXD000593](pride:PXD000593){#intref0065}SRPK1a (CAC39299.1)100Fig. 2Molecular Phylogenetic analysis by the Maximum Likelihood method. The evolutionary history was inferred by using the Maximum Likelihood method based on the JTT matrix-based model [@bib11]. The tree with the highest log likelihood (−6947.2720) is shown. Initial tree(s) for the heuristic search were obtained automatically by applying Neighbor-Join and BioNJ algorithms to a matrix of pairwise distances estimated using a JTT model, and then selecting the topology with superior log likelihood value. The tree is drawn to scale, with branch lengths measured in the number of substitutions per site (above the branches). The analysis involved 49 amino acid sequences (the corresponding accession numbers in the NCBI protein database, are indicated; see also [Fig. 1](#fig1){ref-type="fig"}). All positions containing gaps and missing data were eliminated. There were a total of 605 positions in the final dataset. Evolutionary analyses were conducted in MEGA6 [@bib5].Fig. 2

2. Experimental design, materials and methods {#sec2}
=============================================

Sequence similarity searches and multiple sequence alignments were performed using the NCBI tools: Sequence Read Archive (SRA) BLASTN [@bib6], BLASTP [@bib7] and COBALT [@bib8], respectively. The GeneDoc tool [@bib9] was employed for conservation-based color visualizations of the alignments and production of the alignment figures. The PeptideMass tool in default settings [@bib10] was used to retrieve *in silico* specific SRPK1a peptide sequences, following *in silico* trypsin digestion of the human SRPK1a mRNA (AJ318054.1) 22-534nt segment translated into protein (sequence included within the arrows in [Fig. 1](#fig1){ref-type="fig"}). The resulting peptides were then used as queries in the PRIDE database [@bib3], [@bib4]. Evolutionary analyses and drawing of the phylogenetic tree were conducted by the Maximum Likelihood method in MEGA6 [@bib5]. Annotations of organisms were done manually, based on the known classification of the organisms described in the COBALT output.
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